两性霉素B的脂质制剂。毒性较低，但代价几何？ - Suppr

Suppr

超能文献

Lipid formulations of amphotericin B. Less toxicity but at what economic cost?

作者信息

Tollemar J, Ringdén O

机构信息

Department of Transplantation Surgery, Huddinge Hospital, Karolinska Institutet, Stockholm, Sweden.

出版信息

Drug Saf. 1995 Oct;13(4):207-18. doi: 10.2165/00002018-199513040-00001.

DOI:10.2165/00002018-199513040-00001

PMID:8573294

Abstract

摘要

相似文献

Lipid formulations of amphotericin B. Less toxicity but at what economic cost?两性霉素B的脂质制剂。毒性较低，但代价几何？

Drug Saf. 1995 Oct;13(4):207-18. doi: 10.2165/00002018-199513040-00001.

Amphotericin B: is a lipid-formulation gold standard feasible?两性霉素B：脂质体制剂的金标准是否可行？

Clin Infect Dis. 2004 Jan 15;38(2):304-5; author reply 306-7. doi: 10.1086/380844.

Lipid formulations of polyene antifungal drugs and attenuation of associated nephrotoxicity.多烯抗真菌药物的脂质制剂及其相关肾毒性的减轻

Nephron. 2001 Nov;89(3):251-4. doi: 10.1159/000046081.

Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.两性霉素B脂质制剂用于发热伴中性粒细胞减少症的经验性治疗。

Clin Infect Dis. 2002 Oct 1;35(7):896-7; author reply 897-8. doi: 10.1086/342564.

Lipid formulations of amphotericins: are you a lumper or a splitter?两性霉素的脂质制剂：你是统合者还是区分者？

Clin Infect Dis. 2002 Oct 1;35(7):891-5. doi: 10.1086/342563. Epub 2002 Sep 16.

Lipid formulations of amphotericin B.两性霉素B的脂质制剂

Cleve Clin J Med. 1998 Sep;65(8):423-7. doi: 10.3949/ccjm.65.8.423.

Long-term cost-effectiveness of lipid formulations of amphotericin B in the empirical therapy of invasive mycosis in a developing country.两性霉素B脂质制剂在发展中国家侵袭性真菌病经验性治疗中的长期成本效益

Rev Iberoam Micol. 2017 Oct-Dec;34(4):247-248. doi: 10.1016/j.riam.2017.03.003. Epub 2017 Jul 23.

What is the current and future status of conventional amphotericin B?传统两性霉素B的现状及未来发展趋势如何？

Int J Antimicrob Agents. 2006 Jun;27 Suppl 1:12-6. doi: 10.1016/j.ijantimicag.2006.03.013. Epub 2006 May 16.

Lipid amphotericin B formulations as comparators in clinical trials.脂质两性霉素B制剂在临床试验中作为对照物。

Clin Infect Dis. 2004 Jan 15;38(2):305-6; author reply 306-7. doi: 10.1086/381269.

Lipid-based antifungal agents: a concise overview.基于脂质的抗真菌药物：简要概述。

Cell Mol Biol Lett. 2002;7(3):919-22.

引用本文的文献

Liposomes as nanomedical devices.作为纳米医疗设备的脂质体。

Int J Nanomedicine. 2015 Feb 2;10:975-99. doi: 10.2147/IJN.S68861. eCollection 2015.

Economic evaluation of intravenous itraconazole for presumed systemic fungal infections in neutropenic patients in Korea.韩国中性粒细胞减少患者疑似系统性真菌感染的静脉注射伊曲康唑的经济学评价

Int J Hematol. 2005 Oct;82(3):251-8. doi: 10.1532/IJH97.A30504.

The cost of treating systemic fungal infections.治疗全身性真菌感染的费用。

Drugs. 2001;61 Suppl 1:49-56. doi: 10.2165/00003495-200161001-00005.

Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.两性霉素 B 胶体分散体。关于其用于治疗全身性真菌感染和内脏利什曼病的综述。

Drugs. 1998 Sep;56(3):365-83. doi: 10.2165/00003495-199856030-00008.

Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.脂质体两性霉素B。在真菌感染和内脏利什曼病治疗中的应用。

Drugs. 1998 Apr;55(4):585-612. doi: 10.2165/00003495-199855040-00008.

Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.两性霉素B不同制剂对小鼠内脏利什曼病疗效的比较。

Antimicrob Agents Chemother. 1997 Oct;41(10):2089-92. doi: 10.1128/AAC.41.10.2089.

Bone marrow transplantation using unrelated donors for haematological malignancies.使用无关供体进行血液系统恶性肿瘤的骨髓移植。

Med Oncol. 1997 Mar;14(1):11-22. doi: 10.1007/BF02990940.

Advanced and controlled drug delivery systems in clinical disease management.临床疾病管理中的先进与可控药物递送系统

Pharm World Sci. 1996 Oct;18(5):153-62. doi: 10.1007/BF00820726.

本文引用的文献

NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS.两性霉素B的肾毒性；81例患者的早期和晚期影响

Ann Intern Med. 1964 Aug;61:175-87. doi: 10.7326/0003-4819-61-2-175.

Cost-effectiveness analysis of treatment with liposomal amphotericin B versus conventional amphotericin B in organ or bone marrow transplant recipients with systemic mycoses.脂质体两性霉素B与传统两性霉素B治疗器官或骨髓移植受者系统性真菌病的成本效益分析。

Pharmacoeconomics. 1992 Dec;2(6):500-8. doi: 10.2165/00019053-199202060-00008.

Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.两性霉素B脂质复合物注射液（ABLC）对患有危及生命的系统性霉菌病的骨髓移植受者的疗效。

Bone Marrow Transplant. 1997 Feb;19(4):343-7. doi: 10.1038/sj.bmt.1700664.

Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.脂质体两性霉素B在异基因骨髓移植受者中的安全性和有效性。

Mycoses. 1996 May-Jun;39(5-6):185-93. doi: 10.1111/j.1439-0507.1996.tb00123.x.

Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS.23例艾滋病患者使用两性霉素B脂质体（安必素）治疗隐球菌病。

AIDS. 1993 Jun;7(6):829-35. doi: 10.1097/00002030-199306000-00011.

Liposomal amphotericin B (AmBisome) treatment of invasive fungal infections in immunocompromised children.脂质体两性霉素B（安必素）治疗免疫功能低下儿童侵袭性真菌感染

Mycoses. 1993 May-Jun;36(5-6):187-92. doi: 10.1111/j.1439-0507.1993.tb00748.x.

Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.脂质体两性霉素B（安必素）预防骨髓移植受者侵袭性真菌感染的随机双盲研究。

Bone Marrow Transplant. 1993 Dec;12(6):577-82.

Clinical use of liposomal and lipid-complexed amphotericin B.脂质体和脂质复合两性霉素B的临床应用。

J Antimicrob Chemother. 1994 May;33(5):907-16. doi: 10.1093/jac/33.5.907.

Amphotericin B-induced nephrogenic diabetes insipidus: resolution with its liposomal counterpart.两性霉素B诱发的肾性尿崩症：改用其脂质体制剂后症状缓解

Bone Marrow Transplant. 1994 Jan;13(1):107-8.

Detection of Candida albicans DNA in serum by polymerase chain reaction.通过聚合酶链反应检测血清中的白色念珠菌DNA。

Scand J Infect Dis. 1994;26(4):479-85. doi: 10.3109/00365549409008623.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验